Search

Your search keyword '"Juha Rinne"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Juha Rinne" Remove constraint Author: "Juha Rinne"
44 results on '"Juha Rinne"'

Search Results

1. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer’s disease

2. Effect of xenon on brain injury, neurological outcome, and survival in patients after aneurysmal subarachnoid hemorrhage—study protocol for a randomized clinical trial

3. Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals

4. Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort

5. Kinetic Modeling of Brain [18-F]FDG Positron Emission Tomography Time Activity Curves with Input Function Recovery (IR) Method

6. Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD

7. Recontacting biobank participants to collect lifestyle, behavioural and cognitive information via online questionnaires: lessons from a pilot study within FinnGen

8. Atlas of type 2 dopamine receptors in the human brain: Age and sex dependent variability in a large PET cohort

9. 27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial

10. Sleep apnoea is a risk factor for severe COVID-19

11. Cerebral grey matter density is associated with neuroreceptor and neurotransporter availability: A combined PET and MRI study

12. Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)

13. Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL

14. Interindividual variability and lateralization of μ-opioid receptors in the human brain

15. Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis

16. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species

17. Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis

18. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

19. Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double‐Blind, Multicenter Phase 1 Trial

20. The role of brain integrity in the association between occupational complexity and cognitive performance in subjects with increased risk of dementia

21. New insights into the genetic etiology of Alzheimer's disease and related dementias

22. Neuroinflammation In Parkinson’s Disease: A Study With [11C]PBR28 PET And Cerebrospinal Fluid Markers

23. Atlas of type 2 dopamine receptors in the human brain: Age and sex dependent variability in a large PET cohort

24. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies

25. Domain-specific cognitive effects of white matter pathology in old age, mild cognitive impairment and Alzheimer’s disease

26. Comparison of high and low molar activity TSPO tracer [18F]F-DPA in a mouse model of Alzheimer’s disease

27. Chronic diseases and objectively monitored physical activity profile among aged individuals – a cross-sectional twin cohort study

29. A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

30. Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise

31. [Investments of research and treatment of brain diseases will pay of time]

33. Cholinergic activity correlates with reserve proxies in Alzheimer's disease

34. O3‐13‐03: ARGO trial

35. [Brain imaging of patients with memory disorders]

36. [Update on current care guidelines. The diagnosis and medical treatment of memory disorders]

37. Biodistribution and blood metabolism of 1-11C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET

38. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease

39. Herpesviruses in brains in Alzheimer's and Parkinson's diseases

40. Reply

41. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.

42. Aivosairaudet ovat kalleimmat kansantautimme

Catalog

Books, media, physical & digital resources